DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas to participate at Foundation Sante Biotechnology Conference at Samos, Greece
News | 07. 11. 2008
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.